It's been a busy week in politics, with everything from a surprising Senate decision to a potential federal intervention. Here's a rundown of the stories that mattered.

Fetterman and McCormick: Friends or Foes?

Sen. John Fetterman (D-Pa.) dropped a bombshell this week: he won't campaign against Sen. Dave McCormick (R-Pa.) in 2030. Fetterman emphasized their close relationship, which has been on display through their joint fundraising committee and collaborative legislative efforts. He even hinted he might endorse McCormick. That's a rare bipartisan move in today's climate, and it's turning heads.

Trump vs. Mamdani's Tax

Former President Donald Trump is exploring federal intervention to challenge New York City Mayor Zohran Mamdani's luxury second-home tax. Trump called it a "dangerous political experiment" that could hurt the city. The tax, part of New York's state budget, is expected to rake in around $500 million annually. It's a big number, and the fight over it is just getting started.

Christie's Iran Warning

Former New Jersey Gov. Chris Christie is drawing comparisons between President Donald Trump and former President Jimmy Carter, and not in a flattering way. Christie argues the U.S. is becoming vulnerable to Iran's influence over the Strait of Hormuz, a critical chokepoint for global oil shipments. He criticized Trump for lacking a clear strategy on Iran, warning that the situation could leave the president and the global economy at risk. Strong words from a fellow Republican.

World Liberty Financial's Big Move

On Friday, World Liberty Financial (CRYPTO: WLFI), a crypto platform co-founded by Trump family members, secured conditional approval for a national trust bank charter through World Liberty Trust Co. This charter would let the firm issue stablecoins directly, cutting out third-party provider BitGo (NYSE: BTGO). It's a significant step for the crypto industry and a sign of how intertwined politics and digital assets have become.

EPA in the Crosshairs

Environmental and community groups have filed a lawsuit against the Trump administration, challenging the EPA's approval of two chemicals used in semiconductor manufacturing. The lawsuit claims the EPA's consent orders didn't even disclose the names of the chemicals. The agency approved the first one despite reproductive and developmental risks from exposure through drinking water and air. It's a classic case of industry needs versus public health, and the courts will have to sort it out.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by MarketDash editors.